研究
2023 研究業績・論文発表
論文
Bachir Taouli, Ahmed Ba-Ssalamah, Julius Chapiro, Jagpreet Chhatwal, Kathryn Fowler, Tae Wook Kang, Gesine Knobloch, Dow-Mu Koh, Masatoshi Kudo, Jeong Min Lee …
Correction to: Consensus report from the 10th Global Forum for Liver Magnetic Resonance Imaging: developments in HCC management.
European radiology 2023年12月19日
Arndt Vogel, Richard S Finn, Marie-Hélène Blanchet Zumofen, Carolina Heuser, Javier Sanchez Alvarez, Michael Leibfried, Catherine R Mitchell, Sarah Batson, Gabrielle Redhead, Vincent E Gaillard …
Atezolizumab in Combination with Bevacizumab for the Management of Patients with Hepatocellular Carcinoma in the First-Line Setting: Systematic Literature Review and Meta-Analysis.
Liver cancer 12(6) 510-520 2023年12月
Masatoshi Kudo
Current Therapeutic Strategies for Hepatocellular Carcinoma in Japan.
Liver cancer 12(6) 497-509 2023年12月
Naoshi Nishida, Masatoshi Kudo
Genetic/epigenetic alteration and tumor immune microenvironment in intrahepatic cholangiocarcinoma: Transforming the immune microenvironment with molecular targeted agents
Liver Cancer (in press) 1-14 2023年12月 査読有り
Federico Rossari, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Changhoon Yoo, Jaekyung Cheon, Fabian Finkelmeier, Ho Yeong Lim, José Presa …
α-FAtE: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma.
International journal of cancer 2023年11月23日
Takeshi Hatanaka, Satoru Kakizaki, Atsushi Hiraoka, Toshifumi Tada, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi …
Comparing the impact of atezolizumab plus bevacizumab and lenvatinib on the liver function in hepatocellular carcinoma patients: A mixed-effects regression model approach.
Cancer medicine 2023年11月21日
Hironobu Sugimori, Sho Masaki, Hajime Honjo, Masatoshi Kudo, Tomohiro Watanabe
Visualization of Gastrointestinal Bezoar Movement Causing and Releasing Small Bowel Obstruction on Computed Tomography in a Patient With Diabetes Mellitus
Cureus 15(11) e49133 2023年11月20日
Takeshi Hatanaka, Satoru Kakizaki, Atsushi Hiraoka, Toshifumi Tada, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi …
A comparative analysis of the therapeutic outcomes of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma patients aged 80 years and older: A multicenter study.
Hepatology research : the official journal of the Japan Society of Hepatology
Hepatology research : the official journal of the Japan Society of Hepatology 2023年11月20日
Ciro Celsa, Giuseppe Cabibbo, Claudia Am Fulgenzi, Bernhard Scheiner, Antonio d'Alessio, Giulia F Manfredi, Naoshi Nishida, Celina Ang, Thomas U Marron, Anwaar Saeed …
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours.
Journal of hepatology 2023年11月14日
Kazuya Kariyama, Kazuhiro Nouso, Atsushi Hiraoka, Hidenori Toyoda, Toshifumi Tada, Kunihiko Tsuji, Toru Ishikawa, Takeshi Hatanaka, Ei Itobayashi, Koichi Takaguchi …
Treatment options for solitary hepatocellular carcinoma ≤5 cm: Surgery vs Ablation: A multicenter retrospective study.
Journal of liver cancer 2023年11月6日
Bachir Taouli, Ahmed Ba-Ssalamah, Julius Chapiro, Jagpreet Chhatwal, Kathryn Fowler, Tae Wook Kang, Gesine Knobloch, Dow-Mu Koh, Masatoshi Kudo, Jeong Min Lee …
Correction: Consensus report from the 10th global forum for liver magnetic resonance imaging: multidisciplinary team discussion.
European radiology 2023年11月6日
Teerha Piratvisuth, Jinlin Hou, Tawesak Tanwandee, Thomas Berg, Arndt Vogel, Jörg Trojan, Enrico N De Toni, Masatoshi Kudo, Anja Eiblmaier, Hanns-Georg Klein …
Development and clinical validation of a novel algorithmic score (GAAD) for detecting HCC in prospective cohort studies.
Hepatology communications 7(11) 2023年11月1日
Shukui Qin, Minshan Chen, Ann-Lii Cheng, Ahmed O Kaseb, Masatoshi Kudo, Han Chu Lee, Adam C Yopp, Jian Zhou, Lu Wang, Xiaoyu Wen …
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial.
Lancet (London, England) 2023年10月20日
Yasuo Otsuka, Akane Hara, Kosuke Minaga, Ikue Sekai, Masayuki Kurimoto, Yasuhiro Masuta, Ryutaro Takada, Tomoe Yoshikawa, Ken Kamata, Masatoshi Kudo …
Leucine-rich repeat kinase 2 promotes the development of experimental severe acute pancreatitis
Clinical and Experimental Immunology 2023年10月17日
Yoriaki Komeda, George Tribonias, Masashi Kono, Kohei Handa, Shunsuke Omoto, Mamoru Takenaka, Satoru Hagiwara, Naoko Tsuji, Naoshi Nishida, Hiroshi Kashida …
Real-World Data on Short-Term and Long-Term Treatment Results of Ustekinumab in Patients with Steroid-Resistant/Dependent Ulcerative Colitis
Inflammatory Intestinal Diseases 8(4) 161-166 2023年10月5日
Toshifumi Tada, Takashi Kumada, Atsushi Hiraoka, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi …
Comparison of prognostic impact of atezolizumab plus bevacizumab versus lenvatinib in patients with intermediate-stage hepatocellular carcinoma.
Liver international : official journal of the International Association for the Study of the Liver 2023年10月3日
Masatoshi Kudo, Richard S Finn, Ann-Lii Cheng, Andrew X Zhu, Michel Ducreux, Peter R Galle, Naoya Sakamoto, Naoya Kato, Michitaka Nakano, Jing Jia …
Albumin-Bilirubin Grade Analyses of Atezolizumab plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: A Post Hoc Analysis of the Phase III IMbrave150 Study.
Liver cancer 12(5) 479-493 2023年10月
Masatoshi Kudo
All Stages of Hepatocellular Carcinoma Patients Benefit from Systemic Therapy Combined with Locoregional Therapy.
Liver cancer 12(5) 395-404 2023年10月
Ken Kamata, Hajime Imai, Hisakazu Matsumoto, Yukitaka Yamashita, Takao Kato, Katsuhisa Nishi, Shunsuke Omoto, Kosuke Minaga, Kentaro Yamao, Tomoko Hyodo …
Low‐dose gemcitabine plus nab‐paclitaxel versus standard‐dose gemcitabine plus nab‐paclitaxel in elderly patients with metastatic pancreatic cancer: A randomized Phase
JGH Open 7(9) 659-666 2023年9月7日
Ghassan K Abou-Alfa, George Lau, Masatoshi Kudo, Stephen L Chan, Robin Kate Kelley, Junji Furuse, Wattana Sukeepaisarnjaroen, Yoon Koo Kang, Tu Van Dao, Enrico N De Toni …
Plain language summary of the HIMALAYA study: tremelimumab and durvalumab for unresectable hepatocellular carcinoma (liver cancer).
Future oncology (London, England) 2023年9月6日
Masatoshi Kudo
Drug-Off Criteria in Patients with Hepatocellular Carcinoma Who Achieved Clinical Complete Response after Combination Immunotherapy Combined with Locoregional Therapy.
Liver cancer 12(4) 289-296 2023年9月
Philippe Merle, Masatoshi Kudo, Julien Edeline, Mohamed Bouattour, Ann-Lii Cheng, Stephen L Chan, Thomas Yau, Marcelo Garrido, Jennifer Knox, Bruno Daniele …
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Longer Term Follow-Up from the Phase 3 KEYNOTE-240 Trial.
Liver cancer 12(4) 309-320 2023年9月
Yasuo Otsuka, Kosuke Minaga, Akane Hara, Yasuhiro Masuta, Mamoru Takenaka, Masatoshi Kudo
Piercing technique for mucosal hyperplasia at an uncovered part of a partially covered stent after endoscopic ultrasound-guided hepaticogastrostomy.
Endoscopy international open 11(9) E811-E813 2023年9月
Mamoru Takenaka, Tae Hoon Lee, Masatoshi Kudo
Glove box method: Simple and effective right-hand free method for interventional endoscopy.
Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society 2023年8月31日
Laurent Peyrin-Biroulet, Jessica R Allegretti, David T Rubin, Brian Bressler, Matthew Germinaro, Kuan-Hsiang Gary Huang, Nicole Shipitofsky, Hongyan Zhang, Rebbecca Wilson, Chenglong Han …
Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study.
Gastroenterology 2023年8月31日
Shunsuke Omoto, Mamoru Takenaka, Tomohiro Fukunaga, Ayana Okamoto, Yoriaki Komeda, Seok Jeong, Masatoshi Kudo
Diagnosis of an intraductal papillary neoplasm of the bile duct with fibrovascular stalks using detective flow imaging
Endoscopy 55(S 01) E1012-E1014 2023年8月30日
Enrui Xie, Yee Hui Yeo, Bernhard Scheiner, Yue Zhang, Atsushi Hiraoka, Xinxing Tantai, Petros Fessas, Tiago de Castro, Antonio D'Alessio, Claudia Angela Maria Fulgenzi …
Immune Checkpoint Inhibitors for Child-Pugh Class B Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
JAMA oncology 2023年8月24日
Ken Kamata, Mamoru Takenaka, Naoshi Nishida, Akane Hara, Yasuo Otsuka, Hidekazu Tanaka, Shunsuke Omoto, Kosuke Minaga, Kentaro Yamao, Yasutaka Chiba …
Impact of Smad4 and p53 mutations on the prognosis of patients with pancreatic ductal adenocarcinoma undergoing chemotherapy.
International journal of clinical oncology 28(11) 1511-1519 2023年8月18日
Hiroko Iijima, Masatoshi Kudo, Shoji Kubo, Masayuki Kurosaki, Michiie Sakamoto, Shuichiro Shiina, Ryosuke Tateishi, Osamu Nakashima, Takumi Fukumoto, Yutaka Matsuyama …
Report of the 23rd Nationwide Follow-Up Survey of Primary Liver Cancer in Japan (2014-2015).
Hepatology research : the official journal of the Japan Society of Hepatology 53(10) 895-959 2023年8月13日
Masashi Kono, Yoriaki Komeda, George Tribonias, Saki Yoshida, Kenji Nomura, Kohei Handa, Tomoyuki Nagai, Satoru Hagiwara, Shunsuke Omoto, Mamoru Takenaka …
Serum leucine‐rich alpha‐2 glycoprotein in monitoring disease activity and intestinal mucosal healing for biotherapy‐naïve cases with ulcerative colitis
JGH Open 7(8) 579-583 2023年8月3日
Masatoshi Kudo, Richard S Finn, Peter R Galle, Andrew X Zhu, Michel Ducreux, Ann-Lii Cheng, Masafumi Ikeda, Kaoru Tsuchiya, Ken-Ichi Aoki, Jing Jia …
IMbrave150: Efficacy and Safety of Atezolizumab plus Bevacizumab versus Sorafenib in Patients with Barcelona Clinic Liver Cancer Stage B Unresectable Hepatocellular Carcinoma: An Exploratory Analysis of the Phase III Study.
Liver cancer 12(3) 238-250 2023年8月
Bachir Taouli, Ahmed Ba-Ssalamah, Julius Chapiro, Jagpreet Chhatwal, Kathryn Fowler, Tae Wook Kang, Gesine Knobloch, Dow-Mu Koh, Masatoshi Kudo, Jeong Min Lee …
Consensus report from the 10th global forum for liver magnetic resonance imaging: multidisciplinary team discussion.
European radiology 2023年7月13日
Masatoshi Kudo, Kazuomi Ueshima, Issei Saeki, Toru Ishikawa, Yoshitaka Inaba, Naoki Morimoto, Hiroshi Aikata, Nobukazu Tanabe, Yoshiyuki Wada, Yasuteru Kondo …
A Phase 2, Prospective, Multicenter, Single-arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-stage Hepatocellular Carcinoma: TACTICS-L Trial
LIVER CANCER 13(1) 99-112 2023年6月
Masatoshi Kudo
Adjuvant atezolizumab-bevacizumab after curative therapy for hepatocellular carcinoma.
Hepatobiliary surgery and nutrition 12(3) 435-439 2023年6月1日
Tomohiro Watanabe, Kosuke Minaga, Hajime Honjo, Masatoshi Kudo
Oral administration of ovalbumin protects mice from concanavalin A-induced hepatitis through suppression of interferon-gamma responses
Biochemical and Biophysical Research Communications 674 117-123 2023年6月
Philippe Merle, Masatoshi Kudo, Stanimira Krotneva, Kirhan Ozgurdal, Yun Su, Irina Proskorovsky
Regorafenib versus Cabozantinib as a Second-Line Treatment for Advanced Hepatocellular Carcinoma: An Anchored Matching-Adjusted Indirect Comparison of Efficacy and Safety.
Liver cancer 12(2) 145-155 2023年6月
Masatoshi Kudo
Surveillance, Diagnosis, and Treatment Outcome of Hepatocellular Carcinoma in Japan: 2023 Update.
Liver cancer 12(2) 95-102 2023年6月
Bruno Sangro, Thomas Yau, Anthony B El-Khoueiry, Masatoshi Kudo, Yun Shen, Marina Tschaika, Amit Roy, Yan Feng, Ling Gao, Urvi Aras
Exposure-response analysis for nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma (CheckMate 040).
Clinical and translational science 2023年5月11日
Ken Kamata, Akane Hara, Kosuke Minaga, Tomoe Yoshikawa, Masayuki Kurimoto, Ikue Sekai, Natsuki Okai, Naoya Omaru, Yasuhiro Masuta, Yasuo Otsuka …
Activation of the aryl hydrocarbon receptor inhibits the development of experimental autoimmune pancreatitis through IL-22-mediated signaling pathways
Clinical and Experimental Immunology 2023年5月11日
Hajime Honjo, Yasuhiro Masuta, Yasuo Otsuka, Sho Masaki, Kosuke Minaga, Masatoshi Kudo, Tomohiro Watanabe
Analyses of cytokine gene expression and fecal microbiota in a patient with Cronkhite‐Canada syndrome successfully treated with prednisolone
DEN Open 4(1) e222 2023年5月8日 査読有り
Shunsuke Omoto, Mamoru Takenaka, Tomohiro Fukunaga, Kota Takashima, Yoriaki Komeda, Seok Jeong, Masatoshi Kudo
The “echo-free space” technique: a safe and reliable method for endoscopic ultrasound scope insertion
Endoscopy 55(S 01) E698-E699 2023年5月4日
Naoshi Nishida, Tomoko Aoki, Masahiro Morita, Hirokazu Chishina, Masahiro Takita, Hiroshi Ida, Satoru Hagiwara, Yasunori Minami, Kazuomi Ueshima, Masatoshi Kudo
Non-Inflamed Tumor Microenvironment and Methylation/Downregulation of Antigen-Presenting Machineries in Cholangiocarcinoma.
Cancers 15(8) 2023年4月20日
Masahiro Morita, Naoshi Nishida, Tomoko Aoki, Hirokazu Chishina, Masahiro Takita, Hiroshi Ida, Satoru Hagiwara, Yasunori Minami, Kazuomi Ueshima, Masatoshi Kudo
Role of β-Catenin Activation in the Tumor Immune Microenvironment and Immunotherapy of Hepatocellular Carcinoma.
Cancers 15(8) 2023年4月15日
Masatoshi Kudo
The Society for Immunotherapy of Cancer clinical practice guideline on immunotherapy for hepatocellular carcinoma.
Hepatobiliary surgery and nutrition 12(2) 256-260 2023年4月10日
Mara Persano, Margherita Rimini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Jaekyung Cheon, Fabian Finkelmeier, Ho Yeong Lim, José Presa …
Identification of Atezolizumab Plus Bevacizumab Prognostic Index via Recursive Partitioning Analysis in HCC: The ABE Index.
Anticancer research 43(4) 1599-1610 2023年4月
Mathew Vithayathil, Antonio D'Alessio, Claudia Angela Maria Fulgenzi, Naoshi Nishida, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Anwaar Saeed, Brooke Wietharn…
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma.
Hepatology international 2023年4月1日
Takushi Manabe, Chikara Ogawa, Kei Takuma, Mai Nakahara, Kyoko Oura, Tomoko Tadokoro, Koji Fujita, Joji Tani, Mitsushige Shibatoge, Asahiro Morishita …
Usefulness of the Measurement of Psoas Muscle Volume for Sarcopenia Diagnosis in Patients with Liver Disease.
Diagnostics (Basel, Switzerland) 13(7) 2023年3月26日
Margherita Rimini, Mara Persano, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Jaekyung Cheon, Fabian Finkelmeier, Ho Yeong Lim, José Presa …
Real-World Data for Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma: How Does Adherence to the IMbrave150 Trial Inclusion Criteria Impact Prognosis?
Targeted oncology 18(2) 221-233 2023年3月15日
Yasuo Otsuka, Ken Kamata, Masatoshi Kudo
Contrast-Enhanced Harmonic Endoscopic Ultrasound-Guided Puncture for the Patients with Pancreatic Masses.
Diagnostics (Basel, Switzerland) 13(6) 2023年3月8日
Yasuo Otsuka, Yoriaki Komeda, Masayuki Takeda, Takayuki Takahama, Masashi Kono, Mamoru Takenaka, Satoru Hagiwara, Naoshi Nishida, Hiroshi Kashida, Masatoshi Kudo
Long-Term Survival of More than 5 Years with Maintenance Therapy Using Single-Agent Pemetrexed in a Patient with Diffuse Malignant Peritoneal Mesothelioma
Case Reports in Medicine 2023 1-4 2023年2月28日
Kiyoshi Hasegawa, Nobuyuki Takemura, Tatsuya Yamashita, Takeyuki Watadani, Masaki Kaibori, Shoji Kubo, Mitsuo Shimada, Hiroaki Nagano, Etsuro Hatano, Hiroshi Aikata, Hiroko Iijima, Kazuomi Ueshima, Kazuyoshi Ohkawa, Takuya Genda, Kaoru Tsuchiya, Takuji Torimura, Masafumi Ikeda, Junji Furuse, Masaaki Akahane, Satoshi Kobayashi, Hideyuki Sakurai, Atsuya Takeda, Takamichi Murakami, Utaroh Motosugi, Yutaka Matsuyama, Masatoshi Kudo, Ryosuke Tateishi
Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 Version (5th JSH-HCC Guidelines).
Hepatology research : the official journal of the Japan Society of Hepatology 2023年2月24日
Amit G Singal, Masatoshi Kudo, Jordi Bruix
Breakthroughs in hepatocellular carcinoma therapies.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2023年2月20日
Hiroki Kato, Satoru Hagiwara, Naoshi Nishida, Yoriaki Komeda, Akihiro Yoshida, Masatoshi Kudo
A case of transcatheter arterial embolization for intraperitoneal hemorrhage due to giant hepatic segmental arterial mediolysis
Clinical Journal of Gastroenterology 2023年2月2日
Margherita Rimini, Mara Persano, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Jaekyung Cheon, Fabian Finkelmeier, Ho Yeong Lim, José Presa Ramos, Gianluca Masi, Changhoon Yoo, Sara Lonardi, Bernardo Stefanini, Takashi Kumada, Naoya Sakamoto, Hideki Iwamoto, Tomoko Aoki, Hong Jae Chon, Vera Himmelsbach, Margarida Montes, Caterina Vivaldi, Caterina Soldà, Atsushi Hiraoka, Takuya Sho, Takashi Niizeki, Naoshi Nishida, Christoph Steup, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Hisashi Kosaka, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Valentina Burgio, Angelo Della Corte, Francesca Ratti, Francesco De Cobelli, Luca Aldrighetti, Mario Scartozzi, Stefano Cascinu, Andrea Casadei-Gardini
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Oncology 2023年1月19日
Daizen Hirata, Hiroshi Kashida, Tsuguhiro Matsumoto, Chikara Ebisutani, Akira Teramoto, Mineo Iwatate, Santa Hattori, Mikio Fujita, Wataru Sano, Yoriaki Komeda, Yasushi Sano, Yoshitaka Murakami, Masatoshi Kudo
A Multicenter Prospective Validation Study on Selective Endoscopic Resection of Sessile Serrated Lesions Using Magnifying Colonoscopy in Clinical Practice
Digestion 1-8 2023年1月17日
Naoya Kato, Masatoshi Kudo, Kaoru Tsuchiya, Atsushi Hagihara, Kazushi Numata, Hiroshi Aikata, Yoshitaka Inaba, Shunsuke Kondo, Kenta Motomura, Naohiro Okano, Masafumi Ikeda, Manabu Morimoto, Shingo Kuroda, Akiko Kimura
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase 2 study.
Hepatology research : the official journal of the Japan Society of Hepatology 2023年1月5日
Junji Furuse, Namiki Izumi, Kenta Motomura, Yoshitaka Inaba, Yoshio Katamura, Yasuteru Kondo, Kazuhisa Yabushita, Katsuaki Motoyoshi, Masatoshi Kudo
Safety and Effectiveness of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice: An Observational Post-Marketing Study in Japan.
Drugs - real world outcomes 2023年1月5日
Yoriaki Komeda, Masashi Kono, Hiroshi Kashida, George Tribonias, Sho Masaki, Ryutaro Takada, Tomoyuki Nagai, Satoru Hagiwara, Naoshi Nishida, Mamoru Takenaka, Hajime Honjo, Shigenaga Matsui, Naoko Tsuji, Masatoshi Kudo
Successful initial tofacitinib treatment for acute severe ulcerative colitis with steroid resistance: a case series.
Annals of gastroenterology 36(1) 97-102 2023年
Shunsuke Fujita, Hajime Honjo, Ryutaro Takada, Akane Hara, Yasuhiro Masuta, Yasuo Otsuka, Kohei Handa, Kosuke Minaga, Shigeyoshi Tsuji, Masatoshi Kudo, Tomohiro Watanabe
Ulcerative Colitis-associated Spondyloarthritis Successfully Treated with Infliximab in the Absence of Enhanced TNF-α Responses
Internal Medicine 2023年